Stay updated on CDX-0159 in Chronic Urticaria: Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.

Latest updates to the CDX-0159 in Chronic Urticaria: Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1. No study details or criteria appear to be affected.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; a minor technical update with no visible changes to study content or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check51 days agoChange DetectedExpanded the Locations section to include study sites across the US, Germany, and South Africa and updated the page to version v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check80 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page; no visible changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to CDX-0159 in Chronic Urticaria: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.